Use access key #2 to skip to page content.
$4.26 -0.36 (-7.79%)
10/10/2008 4:00 PM

Array BioPharma, Inc. (ARRY)

CAPS Rating:
***

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

View All Commentary (ARRY)

Recs

1

Avatar Terapixel (93.30) Submitted: 2/08/08 2:19 PM : Outperform Start Price: $5.59 ARRY Score: 9.66

They've got a legitimate six-drug pipeline - scooping up at 52-week low.

Report this Post Replies: 0 | Reply

Featured Broker Partners